Clinical trial design in the era of precision medicine
Elena Fountzilas(European University Cyprus), Razelle Kurzrock(Medical College of Wisconsin), Apostolia M. Tsimberidou(The University of Texas MD Anderson Cancer Center), Henry Hiep Vo(The University of Texas MD Anderson Cancer Center)
Cited by 279
Related Papers
Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
|Molecular Cancer Therapeutics|2017|2.4k
PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy
|Molecular Cancer Therapeutics|2015|2.3k
Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review
|Journal of Clinical Oncology|2018|925
Epstein-Barr Virus and Cancer
|Clinical Cancer Research|2004|795
Review of precision cancer medicine: Evolution of the treatment paradigm
|Cancer Treatment Reviews|2020|747